Table 1.
Baseline | 7 days | 30 days | 6 months | 12 months | 24 months | |
---|---|---|---|---|---|---|
Neurological function evaluation | ||||||
NIHSS | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
mRS | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
BI | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Neuro-imaging evaluation | ||||||
Brain CT/MRI | ✓DWI | ✓ | ✓ | ✓ | ✓ | ✓ |
Cerebrovascular CTA/MRA | ✓ | |||||
DSA | ✓ | ✓a | ✓b | ✓ | ||
CTP | ✓ | ✓a | ✓ | ✓ | ✓ | |
Medication | ||||||
Current medication | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Medication compliance | ✓ | ✓ | ✓ | ✓ | ✓ | |
Adverse events | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Physical examination | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Vital signs | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Laboratory tests | ✓ | ✓a | ✓ | ✓ | ✓ | |
Pregnancy test | ✓ | ✓ | ||||
Electrocardiogram | ✓ | ✓ | ||||
Chest X-ray | ✓ | ✓ |
aBypass surgical group only; bIf necessary; CT computed tomography, CTA computed tomography angiography, CTP computed tomography perfusion, DSA digital subtraction angiography, DWI diffusion-weighted imaging, MRA magnetic resonance angiography, MRI magnetic resonance imaging, mRS modified Rankin scale, NIHSS National Institutes of Health Stroke Scale